Cencora, Inc. (COR)
NYSE · Healthcare
Cencora, Inc. Income Statement 2007–2025
| Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | Sep 2008 | Sep 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||||
| Revenue | 321.33B | 293.96B | 262.17B | 238.59B | 213.99B | 189.89B | 179.59B | 167.94B | 153.14B | 146.85B | 135.96B | 119.57B | 87.96B | 78.08B | 78.70B | 77.78B | 71.76B | 70.19B | 65.67B |
| Gross Profit | 11.48B | 9.91B | 8.96B | 8.30B | 6.94B | 5.19B | 5.14B | 4.61B | 4.55B | 4.27B | 3.53B | 2.98B | 2.51B | 2.63B | 2.46B | 2.33B | 2.10B | 2.05B | 2.22B |
| Profitability | |||||||||||||||||||
| Operating Income | 2.63B | 2.18B | 2.34B | 2.37B | 2.35B | -5.14B | 1.11B | 1.44B | 1.06B | 1.53B | 422.2M | 782.1M | 898.4M | 1.30B | 1.19B | 1.09B | 883.7M | 827.9M | 788.7M |
| EBITDA | 3.68B | 3.27B | 3.30B | 3.06B | 2.86B | -4.74B | 1.57B | 1.91B | 1.46B | 1.89B | 670.9M | 970.8M | 1.06B | 1.44B | 1.29B | 1.18B | — | — | — |
| Net Income | 1.55B | 1.51B | 1.75B | 1.70B | 1.54B | -3.41B | 855.4M | 1.66B | 364.5M | 1.43B | -138.2M | 274.2M | 433.7M | 719.0M | 706.6M | 636.7M | 503.4M | 250.6M | 469.2M |
| Per Share Data | |||||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 195M | 200M | 205M | 211M | 208M | 205M | 212M | 220M | 222M | 226M | 218M | 235M | 0M | 257M | 278M | 287M | 303M | 325M | 376M |
Cencora, Inc. Income Statement — FAQ
Cencora, Inc. (COR) income statement over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see COR's income statement history?
The chart and table above show Cencora, Inc.'s income statement by year and by quarter, including the growth rate.